Latest News

An experimental drug, consisting of cells manufactured and implanted in the eye to stimulate optic nerve growth and activity, could be an entirely new way of fighting glaucoma.

BrightFocus Foundation, a nonprofit supporting research worldwide on diseases of mind and sight, has named Nancy Lynn as Senior Vice President, Strategic Partnerships.

BrightFocus Foundation, a leading private funder of research on diseases of mind and sight, has named Diane Bovenkamp, PhD, as its new Vice President, Scientific Affairs.

BrightFocus is funding a clinical trial to try to fight glaucoma with a new drug implanted in the eye that may protect the optic nerve.

BrightFocus Foundation today lauded a new, innovative citizen science project, EyesOnALZ, which recently launched an online game - Stall Catchers - to engage the public in helping researchers analyze Alzheimer’s data in the hopes of more quickly discovering ways to prevent and treat the disease.

The fall 2016 edition of the National Glaucoma Research Report explores a study examining the effects of pressure fluctuations on glaucoma that may lead to new treatment approaches, explains why a dilated eye exam is a must, provides vision tips for winter driving, and more.

Learn about a link between wet and dry macular degeneration and cataracts; a quiz to test your knowledge of macular degeneration; information that you need to know the dry form of this eye disease, and more in the summer edition of macular degeneration newsletter.

BrightFocus Foundation, Geoffrey Beene Foundation Alzheimer’s Initiative, AnthroTronix, and Mindoula, have launched Phase II of the Health-eBrain Study, investigating the impact the Alzheimer’s caregiving experience has on brain and behavioral health.

BrightFocus Foundation joins the nation in mourning the death of Pat Summitt, the winningest college basketball coach of all time.